Inventor · disambiguated record
Angela V. West
Also filed as: WEST ANGELA V · WEST Angela
15 granted patents·12 pending applications·27 citations·filing 2015–2025
89Inventor score
Files withFORMA THERAPEUTICS INC11NIMBUS WADJET INC6ARIAD PHARMA INC4NIMBUS CLIO INC3NIMBUS CLOTHO INC2
Top patents by PatentIndex Score
27 records- 0194US10870648B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·8 cites·24 claims
- 0292US10227342B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Granted Mar 12, 2019·7 cites·14 claims
- 0391US11254674B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·21 claims
- 0491US9796712B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2017·Granted Oct 24, 2017·6 cites·15 claims
- 0590US11814386B2Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·1 cites·20 claims
- 0684US11535618B2Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Dec 27, 2022·2 cites·21 claims
- 0779US2025034136A1Wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 0879US2024150349A1Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0978US11292791B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 1078US2024132499A1Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1177US2025188079A1Inhibiting cyclic amp-responsive element-binding protein (creb)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1275US11958850B2Heteroaryl compounds for kinase inhibitionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Apr 16, 2024·0 cites·22 claims
- 1374US12378242B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·19 claims
- 1473US11787803B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·20 claims
- 1570US12421233B2WRN inhibitorsNIMBUS WADJET INC·Filed 2025·Granted Sep 23, 2025·0 cites·20 claims
- 1670US12344609B2WRN inhibitorsNIMBUS WADJET INC·Filed 2025·Granted Jul 1, 2025·0 cites·26 claims
- 1765US2019218212A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 1863US2025206738A1Wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 1962US12351577B2Inhibiting cyclic AMP-responsive element-binding protein (CREB)FORMA THERAPEUTICS INC·Filed 2020·Granted Jul 8, 2025·0 cites·19 claims
- 2062US2025263399A1Cbl-b modulators and uses thereofNIMBUS CLIO INC·Filed 2025·Application pending·0 cites
- 2162US2025129069A1Triazolo wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 2260US12325697B2CBL-B modulators and uses thereofNIMBUS CLIO INC·Filed 2022·Granted Jun 10, 2025·0 cites·8 claims
- 2352US2025270200A1Ctps1 inhibitors and uses thereofNIMBUS CLOTHO INC·Filed 2023·Application pending·0 cites
- 2451US2025368646A1Tricyclic fused wrn inhibitorsNIMBUS WADJET INC·Filed 2025·Application pending·0 cites
- 2547US2025163038A1Cbl-b modulators and uses thereofNIMBUS CLIO INC·Filed 2022·Application pending·0 cites
- 2646US12331046B2CTPS1 inhibitors and uses thereofNIMBUS CLOTHO INC·Filed 2021·Granted Jun 17, 2025·0 cites·10 claims
- 2733US2017166598A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angela V. West files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →